does the weight come back after stopping glp 1 GLP-1s make you gain back? What the science says Two Years After Stopping GLP-1s,

If GLP-1 receptor agonism, and by extension the dual and triple agonists, and possibly the cleaner endogenous peptides like BRP, operates as a class of geroscience interventions rather than a class of weight-loss drugs that happen to have nice cardiovascular side benefits, then the population for whom these molecules might matter is much larger than the population that currently qualifies for them under any obesity- or diabetes-based prescribing guideline

3 Regarding employer and Affordable Care Act (ACA) health plans, GLP1 drug spending is now among the fastest-growing drug categories, with costs rising faster than any other drug classes

#OncologyInnovation #ProteinDegraders #FutureOfMedicine #PrecisionOncology #FyreignisInsights To view or add a comment, sign in The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting Studies released in recent weeks are fueling optimism and fresh questions about GLP-1 drugs' potential role in cancer prevention and treatment

Order the appropriate quantity